Technical Analysis for EPI - Essa Pharma Inc.

Grade Last Price % Change Price Change
grade A 5.4 2.86% 0.150
EPI closed up 2.86 percent on Friday, January 18, 2019, on 86 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical EPI trend table...

Date Alert Name Type % Chg
Jan 18 New Uptrend Bullish 0.00%
Jan 18 Outside Day Range Expansion 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 2.86%
Jan 17 Volume Surge Other 2.86%
Jan 17 Narrow Range Bar Range Contraction 2.86%
Jan 17 NR7 Range Contraction 2.86%
Jan 17 Wide Bands Range Expansion 2.86%

Older signals for EPI ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
ESSA Pharma Inc. is a Canada-based clinical-stage development pharmaceutical company. The Company is focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer (CRPC). The Company is developing drugs, which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR). The Company's product candidate, EPI-506 is a selective, oral small molecule pro-drug that blocks the N-terminal domain of the AR. EPI-506 is a pro-drug of EPI-002, a stereoisomer of the Company's discovery compound, EPI-001. The Company is conducting a Phase I/II clinical study to determine the safety, tolerability, maximum tolerated dose, pharmacokinetics and efficacy of EPI-506 in patients with metastatic CRPC. It is focused on developing EPI-506 as its clinical-development product candidate. ESSA Pharmaceuticals Corp. is the Company's subsidiary. The Company has not generated any revenues.
Is EPI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.15
52 Week Low 0.195
Average Volume 1,893
200-Day Moving Average 3.2976
50-Day Moving Average 3.831
20-Day Moving Average 3.7005
10-Day Moving Average 4.562
Average True Range 0.3495
ADX 25.53
+DI 48.0786
-DI 20.7044
Chandelier Exit (Long, 3 ATRs ) 4.4415
Chandelier Exit (Short, 3 ATRs ) 3.5485
Upper Bollinger Band 5.7506
Lower Bollinger Band 1.6504
Percent B (%b) 0.91
BandWidth 110.801243
MACD Line 0.467
MACD Signal Line 0.2036
MACD Histogram 0.2634
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.895
Resistance 3 (R3) 5.840 5.620 5.813
Resistance 2 (R2) 5.620 5.494 5.648 5.785
Resistance 1 (R1) 5.510 5.416 5.565 5.565 5.757
Pivot Point 5.290 5.290 5.318 5.318 5.290
Support 1 (S1) 5.180 5.164 5.235 5.235 5.043
Support 2 (S2) 4.960 5.086 4.988 5.015
Support 3 (S3) 4.850 4.960 4.988
Support 4 (S4) 4.905